You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

DENO

Cancer Type: Genitourinary, Prostate      Intent: Palliative
Regimen Category: Evidence-Informed
Funding:
New Drug Funding Program
    Denosumab - Hormone Refractory Prostate Cancer
Exceptional Access Program
    denosumab - Bony metastases in hormone refractory prostate cancer, with specific criteria

You might also be interested in